Market revenue in 2021 | USD 196.6 million |
Market revenue in 2030 | USD 394.6 million |
Growth rate | 8% (CAGR from 2021 to 2030) |
Largest segment | Pcr |
Fastest growing segment | Rapid & Point of Care |
Historical data | 2018 - 2020 |
Base year | 2021 |
Forecast period | 2022 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Microbiology Culture, Immunoassay, PCR, NGS, Mass Spectrometry, Rapid & Point of Care, Other Technology |
Key market players worldwide | BioMerieux SA, Roche, Abbott Laboratories, Hologic Inc, BD, Danaher Corp, Accelerate Diagnostics Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to antimicrobial resistance diagnostics market will help companies and investors design strategic landscapes.
Pcr was the largest segment with a revenue share of 24.72% in 2021. Horizon Databook has segmented the China antimicrobial resistance diagnostics market based on microbiology culture, immunoassay, pcr, ngs, mass spectrometry, rapid & point of care, other technology covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the China antimicrobial resistance diagnostics market, including forecasts for subscribers. This country databook contains high-level insights into China antimicrobial resistance diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account